WCN26-9465 NOVEL THROMBOTIC BIOMARKERS IN HEMODIALYSIS: FLUCTUATION PATTERNS AND CLINICAL UTILITY

Read full text Summarise with VIRAT
Authors: Li Zhu, Xinyu Zhang, Liangying Gan, Li Zuo
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

The four thrombotic biomarkers [thrombin-antithrombin complex (TAT), tissue plasminogen activator-plasminogen activator inhibitor-1 complex (t-PAIC), plasmin-α2 plasmin inhibitor complex (PIC), and thrombomodulin (TM)] are novel coagulation markers that have demonstrated significant prognostic value in various diseases. This study aimed to investigate their fluctuation patterns during hemodialysis (HD) and their predictive value for short-term prognosis.

Fields of Study & Subjects

Blood Coagulation and Thrombosis Mechanisms Dialysis and Renal Disease Management Blood properties and coagulation

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105351–105351
Publication date
25 March 2026
Language
EN